110 related articles for article (PubMed ID: 24811330)
21. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
22. KRAS mutation screening in colorectal cancer: From paper to practice.
Fakih MM
Clin Colorectal Cancer; 2010 Jan; 9(1):22-30. PubMed ID: 20100685
[TBL] [Abstract][Full Text] [Related]
23. KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.
Pang NK; Nga ME; Chin SY; Ismail TM; Lim GL; Soong R; Salto-Tellez M
Cytopathology; 2011 Dec; 22(6):358-64. PubMed ID: 21029218
[TBL] [Abstract][Full Text] [Related]
24. Impact of KRAS mutation on outcome of patients with metastatic colorectal cancer.
Chang YY; Lin JK; Lin TC; Chen WS; Jeng KJ; Yang SH; Wang HS; Lan YT; Lin CC; Liang WY; Chang SC
Hepatogastroenterology; 2014 Oct; 61(135):1946-53. PubMed ID: 25713893
[TBL] [Abstract][Full Text] [Related]
25. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer.
Tie J; Lipton L; Desai J; Gibbs P; Jorissen RN; Christie M; Drummond KJ; Thomson BN; Usatoff V; Evans PM; Pick AW; Knight S; Carne PW; Berry R; Polglase A; McMurrick P; Zhao Q; Busam D; Strausberg RL; Domingo E; Tomlinson IP; Midgley R; Kerr D; Sieber OM
Clin Cancer Res; 2011 Mar; 17(5):1122-30. PubMed ID: 21239505
[TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of KRAS in primary colorectal cancer and matched metastases by means of highly sensitivity molecular assay.
Miglio U; Mezzapelle R; Paganotti A; Allegrini S; Veggiani C; Antona J; Gentilli S; Monga G; Alabiso O; Boldorini R
Pathol Res Pract; 2013 Apr; 209(4):233-6. PubMed ID: 23538047
[TBL] [Abstract][Full Text] [Related]
27. Molecular differences in the KRAS gene mutation between a primary tumor and related metastatic sites - case report and a literature review.
Kosakowska EA; Stec R; Charkiewicz R; Skoczek M; Chyczewski L
Folia Histochem Cytobiol; 2010 Dec; 48(4):597-602. PubMed ID: 21478103
[TBL] [Abstract][Full Text] [Related]
28. RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres.
Boleij A; Tack V; Taylor A; Kafatos G; Jenkins-Anderson S; Tembuyser L; Dequeker E; van Krieken JH
BMC Cancer; 2016 Oct; 16(1):825. PubMed ID: 27784278
[TBL] [Abstract][Full Text] [Related]
29. KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach.
Domagała P; Hybiak J; Sulżyc-Bielicka V; Cybulski C; Ryś J; Domagała W
Pol J Pathol; 2012 Nov; 63(3):145-64. PubMed ID: 23161231
[TBL] [Abstract][Full Text] [Related]
30. KRAS and BRAF mutations in Serbian patients with colorectal cancer.
Jakovljevic K; Malisic E; Cavic M; Krivokuca A; Dobricic J; Jankovic R
J BUON; 2012; 17(3):575-80. PubMed ID: 23033302
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics external quality assessment pilot scheme for KRAS analysis in metastatic colorectal cancer.
Deans ZC; Tull J; Beighton G; Abbs S; Robinson DO; Butler R
Genet Test Mol Biomarkers; 2011 Nov; 15(11):777-83. PubMed ID: 21851273
[TBL] [Abstract][Full Text] [Related]
32. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
Mostert B; Jiang Y; Sieuwerts AM; Wang H; Bolt-de Vries J; Biermann K; Kraan J; Lalmahomed Z; van Galen A; de Weerd V; van der Spoel P; Ramírez-Moreno R; Verhoef C; Ijzermans JN; Wang Y; Gratama JW; Foekens JA; Sleijfer S; Martens JW
Int J Cancer; 2013 Jul; 133(1):130-41. PubMed ID: 23233388
[TBL] [Abstract][Full Text] [Related]
33. [Correlation between KRAS mutations and clinicopathologic features in colorectal carcinomas].
Gao J; Zhang J; Lu T; Li XY; Jia N; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):595-8. PubMed ID: 23157826
[TBL] [Abstract][Full Text] [Related]
34. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
Gao J; Sun ZW; Li YY; Shen L
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
[TBL] [Abstract][Full Text] [Related]
35. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
36. Performance and cost efficiency of KRAS mutation testing for metastatic colorectal cancer in routine diagnosis: the MOKAECM study, a nationwide experience.
Blons H; Rouleau E; Charrier N; Chatellier G; Côté JF; Pages JC; de Fraipont F; Boyer JC; Merlio JP; Morel A; Gorisse MC; de Cremoux P; Leroy K; Milano G; Ouafik L; Merlin JL; Le Corre D; Aucouturier P; Sabourin JC; Nowak F; Frebourg T; Emile JF; Durand-Zaleski I; Laurent-Puig P;
PLoS One; 2013; 8(7):e68945. PubMed ID: 23935912
[TBL] [Abstract][Full Text] [Related]
37. KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma.
Siyar Ekinci A; Demirci U; Cakmak Oksuzoglu B; Ozturk A; Esbah O; Ozatli T; Celik B; Budakoglu B; Turker I; Bal O; Turan N
J BUON; 2015; 20(1):128-35. PubMed ID: 25778307
[TBL] [Abstract][Full Text] [Related]
38. [Detection of KRAS, BRAF, PIK3CA and EGFR gene mutations in colorectal carcinoma].
Ling Y; Ying JM; Qiu T; Shan L; Guo L; Lü N
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):590-4. PubMed ID: 23157825
[TBL] [Abstract][Full Text] [Related]
39. KRAS mutations in primary and metastatic colorectal cancer.
Han CB; Li F; Ma JT; Zou HW
Int J Colorectal Dis; 2013 May; 28(5):731-2. PubMed ID: 22744738
[No Abstract] [Full Text] [Related]
40. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
Vaughn CP; Zobell SD; Furtado LV; Baker CL; Samowitz WS
Genes Chromosomes Cancer; 2011 May; 50(5):307-12. PubMed ID: 21305640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]